Sodium-glucose cotransporters: Functional properties and pharmaceutical potential

J Diabetes Investig. 2020 Jul;11(4):770-782. doi: 10.1111/jdi.13255. Epub 2020 Apr 16.

Abstract

Glucose is the most abundant monosaccharide, and an essential source of energy for most living cells. Glucose transport across the cell membrane is mediated by two types of transporters: facilitative glucose transporters (gene name: solute carrier 2A) and sodium-glucose cotransporters (SGLTs; gene name: solute carrier 5A). Each transporter has its own substrate specificity, distribution, and regulatory mechanisms. Recently, SGLT1 and SGLT2 have attracted much attention as therapeutic targets for various diseases. This review addresses the basal and functional properties of glucose transporters and SGLTs, and describes the pharmaceutical potential of SGLT1 and SGLT2.

Keywords: Antidiabetic drugs; Sodium-glucose cotransporter 1; Sodium-glucose cotransporter 2.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / metabolism*
  • Glucose / metabolism*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Sodium-Glucose Transport Proteins / metabolism*
  • Sodium-Glucose Transporter 1 / metabolism*
  • Sodium-Glucose Transporter 2 / metabolism*
  • Sodium-Glucose Transporter 2 Inhibitors / pharmacology

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transport Proteins
  • Sodium-Glucose Transporter 1
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose